Completion of Acquisition of LifeHealthcare

31 May 2022

NZX/ASX Code: EBO


COMPLETION OF ACQUISITION OF LIFEHEALTHCARE

EBOS Group Limited (EBOS) is pleased to announce that it has completed its acquisition of LifeHealthcare. Details of the acquisition and associated capital raising were announced on 9 December 2021.*

In commenting on the transaction, EBOS’ CEO, John Cullity, said “LifeHealthcare is one of the largest distributors of medical devices in Australia, New Zealand and South East Asia. The acquisition accelerates EBOS’ medical devices strategy and further expands and diversifies our group earnings. We look forward to the business making a meaningful contribution towards our future growth and we are excited to welcome LifeHealthcare’s staff, customers and suppliers to EBOS.”

LifeHealthcare will be reported within the Institutional Healthcare division in EBOS’ financial results from 1 June 2022.


For further information, please contact:

Investors
Martin Krauskopf
General Manager, Mergers & Acquisitions and Investor Relations
+61 3 9918 5555
[email protected]

Media
John Bennetts
Head of Corporate Communications and Affairs
+61 3 9918 5589
[email protected]


Authorised for lodgement with NZX and ASX by Janelle Cain,General Counsel, EBOS Group Limited.

* The details of shares issued to certain management vendors and the terms of the escrow arrangements for those shares are set out in the Capital Change Notice released on NZX and ASX on 31 May 2022.

---

Announcement PDF